Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 4Lung Neoplasms 3Anxiety Disorders 3Solitary Pulmonary Nodule 2Paresthesia 2Multiple Pulmonary Nodules 2Hypesthesia 2Depression 2Brain Neoplasms 2Surgical Wound Infection 1Skin Neoplasms 1Radiation Injuries 1Pulmonary Atelectasis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Prostatic Diseases 1Postoperative Complications 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia 1Laparotomy 1Inflammatory Bowel Diseases 1Hypoxia 1Hematologic Neoplasms 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Radiosurgery 114Temozolomide 104Bevacizumab 71Radiotherapy 67Magnetic Resonance Spectroscopy 67Carboplatin 29pembrolizumab 28Irinotecan 26Surgical Procedures, Operative 25Radiation 23Nivolumab 23Etoposide 22Magnetic Resonance Imaging 21Ipilimumab 21Erlotinib Hydrochloride 21Cyclophosphamide 21Surveys and Questionnaires 19Aminolevulinic Acid 18Specimen Handling 16Pemetrexed 16Mental Status and Dementia Tests 16Cisplatin 16Carmustine 15Topotecan 14Trastuzumab 13Saline Solution 12Neuropsychological Tests 12Gefitinib 11Filgrastim 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Brain Neoplasms × Oxygen × Clear all
NCT05904704 2025-11-14

Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors

OHSU Knight Cancer Institute

Phase NA Withdrawn
CNS

Brain Neoplasms

NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

OHSU Knight Cancer Institute

Phase 2 Recruiting
50 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡